HealthSouth Corp. (NYSE:HLS) COO Mark J. Tarr acquired 6,371 shares of the firm’s stock in a transaction on Wednesday, November 9th. The stock was bought at an average price of $39.29 per share, for a total transaction of $250,316.59. Following the completion of the acquisition, the chief operating officer now owns 238,890 shares of the company’s stock, valued at $9,385,988.10. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Shares of HealthSouth Corp. (NYSE:HLS) opened at 40.72 on Wednesday. The company’s 50-day moving average is $40.19 and its 200 day moving average is $40.45. The company has a market cap of $3.66 billion, a PE ratio of 16.97 and a beta of 0.90. HealthSouth Corp. has a 52-week low of $30.26 and a 52-week high of $43.38.

HealthSouth Corp. (NYSE:HLS) last released its earnings results on Thursday, October 27th. The company reported $0.65 EPS for the quarter, topping the Zacks’ consensus estimate of $0.60 by $0.05. The company had revenue of $926.80 million for the quarter, compared to analysts’ expectations of $448.60 million. HealthSouth Corp. had a return on equity of 29.27% and a net margin of 6.31%. The business’s revenue for the quarter was up 19.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.52 EPS. On average, analysts anticipate that HealthSouth Corp. will post $2.55 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 17th. Stockholders of record on Tuesday, January 3rd will be paid a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 2.36%. The ex-dividend date is Thursday, December 29th. HealthSouth Corp.’s payout ratio is 40.17%.

HLS has been the topic of several research reports. Zacks Investment Research upgraded shares of HealthSouth Corp. from a “hold” rating to a “buy” rating and set a $45.00 price objective on the stock in a report on Monday, October 31st. SunTrust Banks Inc. set a $54.00 price objective on shares of HealthSouth Corp. and gave the company a “buy” rating in a report on Monday, August 1st. Wells Fargo & Co. restated a “buy” rating on shares of HealthSouth Corp. in a research note on Sunday, September 11th. JMP Securities restated a “buy” rating on shares of HealthSouth Corp. in a research note on Sunday, September 4th. Finally, Mizuho downgraded shares of HealthSouth Corp. from a “buy” rating to a “neutral” rating in a research note on Wednesday, November 9th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $46.57.

Several large investors have recently added to or reduced their stakes in HLS. Prudential Financial Inc. boosted its stake in HealthSouth Corp. by 147.5% in the first quarter. Prudential Financial Inc. now owns 22,523 shares of the company’s stock worth $848,000 after buying an additional 13,424 shares during the last quarter. BlackRock Inc. boosted its stake in HealthSouth Corp. by 95.0% in the first quarter. BlackRock Inc. now owns 7,768 shares of the company’s stock worth $292,000 after buying an additional 3,785 shares during the last quarter. BlackRock Group LTD boosted its stake in HealthSouth Corp. by 29.5% in the first quarter. BlackRock Group LTD now owns 65,605 shares of the company’s stock worth $2,467,000 after buying an additional 14,953 shares during the last quarter. State Street Corp boosted its stake in HealthSouth Corp. by 3.4% in the first quarter. State Street Corp now owns 1,880,351 shares of the company’s stock worth $70,753,000 after buying an additional 61,337 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its stake in HealthSouth Corp. by 321.1% in the first quarter. Renaissance Technologies LLC now owns 638,400 shares of the company’s stock worth $24,023,000 after buying an additional 486,800 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

About HealthSouth Corp.

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.

5 Day Chart for NYSE:HLS

Receive News & Stock Ratings for HealthSouth Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp. and related stocks with our FREE daily email newsletter.